|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Cash and due from banks | |||||
| Federal funds sold | |||||
| Interest-bearing deposits in banks | |||||
| Cash and cash equivalents | |||||
| Available-for-sale securities | |||||
| Held-to-maturity securities | |||||
| Loans, net of allowance for credit losses of $19,029,191 and $18,096,173 on September 30, 2026 and December 31, 2025, respectively | |||||
| Premises and equipment, net | |||||
| Restricted stock, at cost | |||||
| Foreclosed assets held for sale, net | |||||
| Interest receivable | |||||
| Bank owned life insurance | |||||
| Core deposits and other intangibles | |||||
| Goodwill | |||||
| Deferred tax asset | |||||
| Other | |||||
| Total assets | |||||
| Liabilities and Shareholders’ Equity | |||||
| Liabilities | |||||
| Demand | |||||
| Savings, NOW and money market | |||||
| Time | |||||
| Total deposits | |||||
| Short-term borrowings | |||||
| Long-term debt | |||||
| Interest payable | |||||
| Other liabilities | |||||
| Total liabilities | |||||
| Shareholders’ equity | |||||
| Common stock $0.01 par value; 50,000,000 shares authorized; 13,710,195 shares issued and outstanding on September 30, 2026; 13,697,987 on December 31, 2025 | |||||
| Additional paid-in capital | |||||
| Retained earnings | |||||
| Accumulated other comprehensive loss | |||||
| Total shareholders’ equity | |||||
| Total liabilities and shareholders’ equity |
Loading...